Literature DB >> 1973635

Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine.

A Sidi1, R F Kaplan, R F Davis.   

Abstract

In a retrospective one-year study, we documented respiratory failure or prolonged neuromuscular blockade in eight of 65 patients with chronic renal failure who had received either vecuronium (four of 29 patients) or atracurium (four of 36 patients) during anaesthesia for kidney transplantation. We reviewed the charts of the patients and recorded all aspects of medication and anaesthesia to try to determine whether there might be a single factor associated with this high incidence (12 per cent) of respiratory failure. Anaesthesia for all patients was induced with thiopentone, isoflurane, and N2O/O2. Tracheal intubation was facilitated with muscle relaxants in a single bolus of vecuronium, 0.07 to 0.1 mg.kg-1, or atracurium, 0.3 to 0.5 mg.kg-1. Additional doses were given according to neuromuscular activity, which was monitored visually by response to train-of-four and tetanic stimulation. Anaesthesia was maintained with fentanyl/isoflurane and N2O/O2. After induction of anaesthesia, each patient received methylprednisolone, cefazolin, mannitol infusion for 24 hr beginning at the start of renal artery anatomosis, and either azathioprine (n = 57) or cyclosporine (n = 8). Relaxation was evaluated toward the end of the operation by train-of-four stimulation. Neuromuscular blockade was reversed with edrophonium (0.75-1 mg.kg-1) or neostigmine (0.06-0.08 mg.kg-1). The eight patients with prolonged neuromuscular blockade received ventilatory support for one to three hours after operation. Respiratory failure was significantly more frequent in patients who received cyclosporine (P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973635     DOI: 10.1007/BF03006323

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  26 in total

1.  Pharmacokinetics of atracurium and other non-depolarizing neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction.

Authors:  R D Miller
Journal:  Br J Anaesth       Date:  1986       Impact factor: 9.166

2.  Tactile and visual evaluation of the response to train-of-four nerve stimulation.

Authors:  J Viby-Mogensen; N H Jensen; J Engbaek; H Ording; L T Skovgaard; B Chraemmer-Jørgensen
Journal:  Anesthesiology       Date:  1985-10       Impact factor: 7.892

3.  Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure.

Authors:  A F Bencini; A H Scaf; Y J Sohn; C Meistelman; A Lienhart; U W Kersten; S Schwarz; S Agoston
Journal:  Anesth Analg       Date:  1986-03       Impact factor: 5.108

4.  Edrophonium antagonism of pancuronium-induced neuromuscular blockade in man: a reappraisal.

Authors:  A F Kopman
Journal:  Anesthesiology       Date:  1979-08       Impact factor: 7.892

5.  Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.

Authors:  M R Fahey; R B Morris; R D Miller; T L Nguyen; R A Upton
Journal:  Br J Anaesth       Date:  1981-10       Impact factor: 9.166

6.  Use of atracurium in patients with no renal function.

Authors:  J M Hunter; R S Jones; J E Utting
Journal:  Br J Anaesth       Date:  1982-12       Impact factor: 9.166

7.  Modification of atracurium blockade by halothane and by suxamethonium. A review of clinical experience.

Authors:  J A Stirt; R L Katz; A L Murray; D L Schehl; C Lee
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

8.  Interactions of diisopropyl phenol (ICI 35868) with suxamethonium, vecuronium and pancuronium in vitro.

Authors:  R J Fragen; L H Booij; F van der Pol; E N Robertson; J F Crul
Journal:  Br J Anaesth       Date:  1983-05       Impact factor: 9.166

9.  Azathioprine: effects on neuromuscular transmission.

Authors:  K L Dretchen; V H Morgenroth; F G Standaert; L F Walts
Journal:  Anesthesiology       Date:  1976-12       Impact factor: 7.892

10.  Interaction of cyclosporin and its solvent, Cremophor, with atracurium and vecuronium. Studies in the cat.

Authors:  L Gramstad; J A Gjerløw; E S Hysing; H E Rugstad
Journal:  Br J Anaesth       Date:  1986-10       Impact factor: 9.166

View more
  7 in total

1.  Neuromuscular blockade and ventilatory failure after cyclosporine.

Authors:  V Kadieva; P V van Heerden; A Roux; L Friedman; D F Morrell
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

2.  Reply.

Authors:  A Sidi
Journal:  Can J Anaesth       Date:  1992-04       Impact factor: 5.063

3.  Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?

Authors:  Koichi Takita; Yukiko Goda; Osamu Kemmotsu; Atsushi Okuyama; Tadayoshi Ito; Hiroshi Sakamoto; Hideyuki Mashio; Hiroshi Kawahigashi
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

4.  Oral cyclosporine-vecuronium interaction.

Authors:  P Ganjoo; P Tewari
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

5.  Renal transplantation-anaesthetic experience of 350 cases.

Authors:  Anand Jain; Vaibhavi Baxi; D Dasgupta
Journal:  Indian J Anaesth       Date:  2009-06

Review 6.  [Anaesthesia for noncardiac surgery in a heart-transplanted patient: a clinical case and review of the literature].

Authors:  Oumarou Mahamane Mamane Nassirou; Abdelhamid Jaafari; Abdellatif Chlouchi; Mustapha Bensghir; Charki Haimeur
Journal:  Pan Afr Med J       Date:  2016-07-28

Review 7.  Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines.

Authors:  Federico Coccolini; Mario Improta; Massimo Sartelli; Kemal Rasa; Robert Sawyer; Raul Coimbra; Massimo Chiarugi; Andrey Litvin; Timothy Hardcastle; Francesco Forfori; Jean-Louis Vincent; Andreas Hecker; Richard Ten Broek; Luigi Bonavina; Mircea Chirica; Ugo Boggi; Emmanuil Pikoulis; Salomone Di Saverio; Philippe Montravers; Goran Augustin; Dario Tartaglia; Enrico Cicuttin; Camilla Cremonini; Bruno Viaggi; Belinda De Simone; Manu Malbrain; Vishal G Shelat; Paola Fugazzola; Luca Ansaloni; Arda Isik; Ines Rubio; Itani Kamal; Francesco Corradi; Antonio Tarasconi; Stefano Gitto; Mauro Podda; Anastasia Pikoulis; Ari Leppaniemi; Marco Ceresoli; Oreste Romeo; Ernest E Moore; Zaza Demetrashvili; Walter L Biffl; Imitiaz Wani; Matti Tolonen; Therese Duane; Sameer Dhingra; Nicola DeAngelis; Edward Tan; Fikri Abu-Zidan; Carlos Ordonez; Yunfeng Cui; Francesco Labricciosa; Gennaro Perrone; Francesco Di Marzo; Andrew Peitzman; Boris Sakakushev; Michael Sugrue; Marja Boermeester; Ramiro Manzano Nunez; Carlos Augusto Gomes; Miklosh Bala; Yoram Kluger; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-08-09       Impact factor: 5.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.